A look back at 2000: overabundance and deregulation.
(1) Ten or 20 years ago about half the new drugs released each year provided no significant advantage for the patient, relative to existing therapeutic means. This proportion has been increasing gradually over the last 5 years. (2) In 2000, approximately 80% of "new" drugs in fact provided "Nothing New" for the patient according to our rating system.
D000329:Advertising / Q000639:trends; D017277:Drug Approval; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000639:trends; D015507:Drugs, Investigational; D005062:European Union; D005544:Forecasting; D005602:France; D019981:Health Care Sector / Q000639:trends; D049674:History, 21st Century; D006801:Humans; D008389:Marketing of Health Services / Q000639:trends
D015507:Drugs, Investigational